Community

Key Takeaways Strong market position and portfolio of leading brands continue to drive revenue growth. New strategic initiative and operating model, emphasizing organic growth within the company portfolio, along with value creation, optimization and streamlining of the portfolio, are expected to sustain future growth and enhance profitability.

My main narrative for FRE: What former CEO Mark Schneider blow up to an inefficient giant, will now be cut down by actual CEO Michael Sen and trimmed on efficiency from formally 4 segments FMC (dialyses), Helios (private hospitals), Kabi(Generic & Infusions), Vamed (Projects & Digitalization) only 2 remain: Helios, Kabi, the other will be sold, and the intakes will help to restructure the financial situation under Mark Schneider the Spanish hospitals were acquired, this was a good deal: privat hospital runs well in Spain, because of their good reputation wealthy Latin Americans travel for medical treatments to Spain I focus also on: More equity than debt. Ratio is at 62% (debt/equity).

Investing in Stryker (SYK) should be an easy ride Key “Take aways”: - Solid balance sheet - Earnings recovered, with positive outlook. - SYK is fair priced.

Key Takeaways I am of the opinion EV is over hyped and the buying public do not fully understand either the true carbon footprint or the practical realities regarding the provision of power Catalysts How knowledgeable are buyers of EV's about the true carbon footprint to produce an EV? Will the discovery and reality of the actual manufacturing carbon footprint make them change their mind and therefore reduce demand?

Mony Group provides financial advice and comparison services in the UK with an emphasis on saving money for its users. During an inflationary period and money being tight at home people are looking to make savings and are likely to be price sensitive.

Key Takeaways Exxon is on the wrong side of secular market trends that favor sustainable energy investing. Revenues are reliant on fossil fuels and are vulnerable to industry headwinds and a potential recession.

Key Takeaways The end of ACP will lead to a short-term revenue decline. Predictive AI is providing more valuable customer service experiences.

Key Takeaways KO can remain a reliable performer in a mature but growing category. Its diversified portfolio of beverages means it can handle shifting beverage preferences Its reduction of debt will help it endure any market volatility, like it has in the past Dividend payout ratio is rising and management will eventually have to address it.

Key Takeaways I expect JNJ to remain an established and mature market performer in a relatively stable sector. Some short-term company-related headwinds are cancelled out by long-term industry-related tailwinds Two main risks come from the talc-related litigation issue and patent expiration Most promising revenue growth opportunities are from cancer therapy drugs, with a TAM of $21.6b.